We Have Become a Shareholder of Neo Auvra.

As a result of the search for new products, new production-sales-distribution relations/regions, new partnerships and cooperations in line with its growth and innovation strategies, our company Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (“GEN”) signed an agreement (“Agreement”) on 25.01.2022 to be a shareholder of the Neo Auvra Dijital Sağlık ve Biyonik Teknolojileri ve Hizmetleri Sanayi ve Ticaret A.Ş. (“Neo Auvra”) which produces cyber-physical systems and technologies for digital holistic health, digital medicine, and digital therapeutics. According to the Agreement, GEN will be a shareholder by joining capital increase.

With this investment, GEN contributed both to its own growth and the development of the investment ecosystem in our country’s field of health technologies.

Neo Auvra Dijital Sağlık ve Biyonik Teknolojileri ve Hizmetleri Sanayi ve Ticaret A.Ş. was established by Bekir Tarcan Kiper and Ömer Kerem Özçakıl, the founding partners of the company, and was registered by the Istanbul Trade Registry on 03.09.2021.

For an unmatched ecological validity and high-fidelity, Assessments are carried out with cyber-physical technologies like; Virtual Reality, Augmented Reality, and eXtended Reality-based interactive scenarios and tasks; including simultaneous biometric data collection with relevant sensors, trackers, wearables, and electrophysiological devices. Currently, Neo Auvra addresses four markets/verticals: Neuropsychology/Neurodegenerative Diseases; Human Resources; Fitness and Sports; and Well-being. Based on its wide spectrum of cognitive, socio-emotional, and physio-physical domains, subdomains, and metrics, and with its modular architecture, Neo Auvra can deliver any bespoke solution for any type of assessment and training needs in those markets.